Rates of severe neutropenia and infection risk in patients treated with deferiprone: 28 years of data. [PDF]
Badawy SM+7 more
europepmc +1 more source
Emerging Isseus in FDA Regulation: Warning Letters, Internet Promotion, and Tobacco [PDF]
Senger, Jeffrey M.
core
Rivaroxaban as an effective alternative to warfarin in a patient with atrial fibrillation, thrombophilia, and left atrial appendage thrombus: a case report [PDF]
core +1 more source
Assessing the Safety of a Novel Monoclonal Antibody Cocktail for Postexposure Prophylaxis in Category III Animal Exposures. [PDF]
Singh A+7 more
europepmc +1 more source
Safety and efficacy of inhalable ambroxol hydrochloride aerosol for adult patients with respiratory diseases: an open-label, single-arm, multicentre study. [PDF]
Ma J+37 more
europepmc +1 more source
Comparison of safety profiles for dapagliflozin based on EMA and FDA safety issues: Challenges and future of post-marketing surveillance in Korea. [PDF]
Park S+5 more
europepmc +1 more source
A Sponsor's Perspective on the Contribution of Regulatory-Required Observational Post-Marketing Studies to Understanding Human Drug Product Benefit/Risk in Japan. [PDF]
Wolter KD+6 more
europepmc +1 more source
One-year Safety and Effectiveness of Ustekinumab in Patients With Crohn's Disease: The K-STAR Study. [PDF]
Lee CK+17 more
europepmc +1 more source
Antiretroviral Use for HIV Prevention During Pregnancy: The Need to Strengthen Regulatory and Surveillance Systems in Africa. [PDF]
Schaefer R+11 more
europepmc +1 more source